KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Long-Term Investments: 2010-2011

Historic Long-Term Investments for Ionis Pharmaceuticals (IONS) over the last 2 years, with Dec 2011 value amounting to -$4.4 million.

  • Ionis Pharmaceuticals' Long-Term Investments fell 76.88% to -$5.6 million in Q3 2012 from the same period last year, while for Sep 2012 it was -$5.6 million, marking a year-over-year decrease of 76.88%. This contributed to the annual value of -$4.4 million for FY2011, which is 408.51% down from last year.
  • Ionis Pharmaceuticals' Long-Term Investments amounted to -$4.4 million in FY2011, which was down 408.51% from -$870,000 recorded in FY2010.
  • Ionis Pharmaceuticals' Long-Term Investments' 5-year high stood at -$870,000 during FY2010, with a 5-year trough of -$4.4 million in FY2011.
  • Over the past 2 years, Ionis Pharmaceuticals' median Long-Term Investments value was -$2.6 million (recorded in 2010), while the average stood at -$2.6 million.
  • Data for Ionis Pharmaceuticals' Long-Term Investments shows a maximum YoY slumped of 408.51% (in 2011) over the last 5 years.
  • Ionis Pharmaceuticals' Long-Term Investments (Yearly) stood at -$870,000 in 2010, then crashed by 408.51% to -$4.4 million in 2011.